Literature DB >> 9849795

Creutzfeldt-Jakob disease via dural and corneal transplants.

C J Lang1, J G Heckmann, B Neundörfer.   

Abstract

A review of all published cases of iatrogenic Creutzfeldt-Jakob disease (CJD) via dural (N=71) and corneal (N=4) transplants is given. All but three of the dural cases were obviously due to a commercial product recalled in 1996. Two of the corneal grafts were taken from patients who had died of sporadic CJD. These cases differed from CJD due to human growth hormone injections and the new variant. Instead. they were akin to sporadic cases, but memory loss, disorders of higher cerebral functions and extrapyramidal signs were fewer, while cerebellar abnormalities were more frequent. Progressive dysarthria and gait disorder/gait ataxia were prominent signs during the early stages, myocloni the most salient feature later. A nonperiodic EEG did not contradict the diagnosis. Using current diagnostic criteria the disease was underdiagnosed ante mortem. Utmost care is needed in selecting, harvesting and handling dural and corneal grafts to avoid inadvertent transmission of CJD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9849795     DOI: 10.1016/s0022-510x(98)00226-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

1.  Disease latency in Creutzfeldt-Jakob disease via dural grafting: a case report.

Authors:  C J Lang; J G Heckmann; V Querner; B Neundörfer; J Kornhuber; M Buchfelder; H A Kretzschmar
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Minimising the risk of prion transmission by contact tonometry.

Authors:  S Z Amin; L Smith; P J Luthert; M E Cheetham; R J Buckley
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

3.  Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein.

Authors:  N Nishida; D A Harris; D Vilette; H Laude; Y Frobert; J Grassi; D Casanova; O Milhavet; S Lehmann
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Sporadic Creutzfeldt-Jakob disease with cerebellar ataxia at onset in the UK.

Authors:  S A Cooper; K L Murray; C A Heath; R G Will; R S G Knight
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-07-11       Impact factor: 10.154

5.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

6.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

7.  Experimental evaluation of new chitin-chitosan graft for duraplasty.

Authors:  M Pogorielov; A Kravtsova; G C Reilly; V Deineka; G Tetteh; O Kalinkevich; O Pogorielova; R Moskalenko; G Tkach
Journal:  J Mater Sci Mater Med       Date:  2017-01-21       Impact factor: 3.896

8.  Prion infection of skeletal muscle cells and papillae in the tongue.

Authors:  Ellyn R Mulcahy; Jason C Bartz; Anthony E Kincaid; Richard A Bessen
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 9.  Prion stability and infectivity in the environment.

Authors:  Richard C Wiggins
Journal:  Neurochem Res       Date:  2008-05-16       Impact factor: 3.996

10.  MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; S Ramljak; A Krasnianski; U Heinemann; S Eigenbrod; E Gelpi; B Barsic; H A Kretzschmar; W J Schulz-Schaeffer; M Knauth; I Zerr
Journal:  J Neurol       Date:  2009-01-23       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.